| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 1.76e-08 | 16 | 108 | 5 | GO:0004697 | |
| GeneOntologyMolecularFunction | diacylglycerol-dependent, calcium-independent serine/threonine kinase activity | 1.54e-07 | 3 | 108 | 3 | GO:0004699 | |
| GeneOntologyMolecularFunction | integrin binding | 4.95e-06 | 175 | 108 | 8 | GO:0005178 | |
| GeneOntologyMolecularFunction | zinc ion binding | TRHDE FBXO40 MARCHF10 ADAMTS2 PRICKLE1 CHD4 PPARD SIRT6 MEP1A RASGRP1 ITGB1BP2 MIB1 CXXC4 PAPPA PRKCG NR1H2 KDM1B | 5.71e-06 | 891 | 108 | 17 | GO:0008270 |
| GeneOntologyMolecularFunction | transition metal ion binding | TRHDE FBXO40 FN1 MARCHF10 ADAMTS2 PRICKLE1 EGLN1 CHD4 PPARD SIRT6 MEP1A RASGRP1 ITGB1BP2 MIB1 CXXC4 PAPPA PRKCG NR1H2 KDM1B | 1.90e-05 | 1189 | 108 | 19 | GO:0046914 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 7.34e-05 | 188 | 108 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | DAB2IP IPO5 NRG1 IPO7 FN1 SPINK2 CASP8 TBC1D25 PPARD ACSL1 RASGRP1 PRKCD PRKCE PRKCH RPGR RUBCN RECK SPINK5 VEGFA | 2.00e-04 | 1418 | 108 | 19 | GO:0030234 |
| GeneOntologyBiologicalProcess | muscle structure development | NRG1 FBXO40 PRICKLE1 EGLN1 CNTNAP1 LAMA1 LAMB1 PPARD SIRT6 RYR2 PPP3CB ITGB1BP2 CTDP1 ATP11A KLK1 NOTCH2 VEGFA | 1.97e-06 | 858 | 107 | 17 | GO:0061061 |
| GeneOntologyBiologicalProcess | circulatory system development | EPHB2 DAB2IP NRG1 FN1 PRICKLE1 EGLN1 PKD1L1 LAMA1 CASP8 SIRT6 ITGA4 SVEP1 RYR2 PPP3CB MIB1 CTDP1 PLAU KLK1 RECK NOTCH2 SPINK5 VEGFA | 3.96e-06 | 1442 | 107 | 22 | GO:0072359 |
| GeneOntologyBiologicalProcess | regulation of proteolysis | DAB2IP RHBDF2 SPINK2 PRICKLE1 PSMC3 CASP8 GSAP SIRT6 PRKCG PLAU NR1H2 CLEC16A RECK SPINK5 VEGFA | 7.28e-06 | 748 | 107 | 15 | GO:0030162 |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | NRG1 PRICKLE1 EGLN1 CASP8 SIRT6 RYR2 CTDP1 KLK1 NOTCH2 VEGFA | 7.89e-06 | 327 | 107 | 10 | GO:0048738 |
| GeneOntologyBiologicalProcess | heart development | NRG1 FN1 PRICKLE1 EGLN1 PKD1L1 CASP8 SIRT6 ITGA4 RYR2 PPP3CB MIB1 CTDP1 KLK1 NOTCH2 VEGFA | 8.40e-06 | 757 | 107 | 15 | GO:0007507 |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | EPHB2 IPO5 IPO7 PPARD SIRT6 LIMK2 PPP3CB PRKCD PRKCE PRKCH NR1H2 PRKCQ VEGFA | 1.18e-05 | 591 | 107 | 13 | GO:1903829 |
| GeneOntologyBiologicalProcess | striated muscle tissue development | NRG1 PRICKLE1 EGLN1 CASP8 SIRT6 RYR2 CTDP1 KLK1 NOTCH2 VEGFA | 1.39e-05 | 349 | 107 | 10 | GO:0014706 |
| GeneOntologyBiologicalProcess | regulation of Ras protein signal transduction | 1.61e-05 | 61 | 107 | 5 | GO:0046578 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | NRG1 FBXO40 PRICKLE1 CNTNAP1 LAMA1 LAMB1 SIRT6 PPP3CB CTDP1 ATP11A NOTCH2 VEGFA | 2.02e-05 | 531 | 107 | 12 | GO:0042692 |
| GeneOntologyBiologicalProcess | axon development | EPHB2 NRG1 FN1 PRICKLE1 TNC CNTNAP1 LAMA1 LAMB1 ITGA4 PPP3CB PRKCQ NOTCH2 VEGFA | 2.82e-05 | 642 | 107 | 13 | GO:0061564 |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to nucleus | 2.87e-05 | 114 | 107 | 6 | GO:1900182 | |
| GeneOntologyBiologicalProcess | muscle tissue development | NRG1 PRICKLE1 EGLN1 CNTNAP1 CASP8 SIRT6 RYR2 PPP3CB CTDP1 KLK1 NOTCH2 VEGFA | 3.27e-05 | 558 | 107 | 12 | GO:0060537 |
| GeneOntologyBiologicalProcess | response to wounding | EPHB2 NRG1 FN1 TNC PPARD ITGB4 SVEP1 PRKCD PRKCE PLAU PRKCQ NOTCH2 VEGFA | 3.70e-05 | 659 | 107 | 13 | GO:0009611 |
| GeneOntologyBiologicalProcess | regulation of protein localization to nucleus | 3.72e-05 | 176 | 107 | 7 | GO:1900180 | |
| GeneOntologyBiologicalProcess | vasculature development | EPHB2 DAB2IP FN1 PRICKLE1 EGLN1 LAMA1 CASP8 SIRT6 SVEP1 PPP3CB MIB1 PLAU RECK NOTCH2 SPINK5 VEGFA | 3.88e-05 | 969 | 107 | 16 | GO:0001944 |
| GeneOntologyBiologicalProcess | negative regulation of protein metabolic process | EPHB2 DAB2IP IPO5 NRG1 ACOT8 IPO7 SPINK2 PRKCD PRKCE PRKCG PRKCH PLAU NR1H2 CLEC16A RECK SPINK5 VEGFA | 4.34e-05 | 1088 | 107 | 17 | GO:0051248 |
| GeneOntologyBiologicalProcess | heart morphogenesis | 4.51e-05 | 321 | 107 | 9 | GO:0003007 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue morphogenesis | 5.02e-05 | 77 | 107 | 5 | GO:0055008 | |
| GeneOntologyBiologicalProcess | wound healing | EPHB2 NRG1 FN1 PPARD SVEP1 PRKCD PRKCE PLAU PRKCQ NOTCH2 VEGFA | 5.11e-05 | 493 | 107 | 11 | GO:0042060 |
| GeneOntologyBiologicalProcess | protein import into nucleus | 7.12e-05 | 195 | 107 | 7 | GO:0006606 | |
| GeneOntologyBiologicalProcess | negative regulation of catalytic activity | EPHB2 DAB2IP IPO5 IPO7 SPINK2 EGLN1 GFI1 PRKCD PRKCH RECK SPINK5 VEGFA | 8.33e-05 | 615 | 107 | 12 | GO:0043086 |
| GeneOntologyBiologicalProcess | import into nucleus | 8.61e-05 | 201 | 107 | 7 | GO:0051170 | |
| GeneOntologyBiologicalProcess | regulation of autophagosome maturation | 8.75e-05 | 17 | 107 | 3 | GO:1901096 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | EPHB2 NRG1 PRICKLE1 TNC EGLN1 LAMA1 LAMB1 SIRT6 ITGB4 GFI1 RYR2 MIB1 PLAU RPGR USH2A KLK1 NOTCH2 VEGFA | 8.81e-05 | 1269 | 107 | 18 | GO:0009887 |
| GeneOntologyBiologicalProcess | cell growth | DAB2IP NRG1 FN1 PRICKLE1 TNC PPARD SIRT6 ITGA4 PPP3CB CTDP1 PRKCQ VEGFA | 9.70e-05 | 625 | 107 | 12 | GO:0016049 |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 1.13e-04 | 362 | 107 | 9 | GO:0034504 | |
| GeneOntologyBiologicalProcess | muscle tissue morphogenesis | 1.24e-04 | 93 | 107 | 5 | GO:0060415 | |
| GeneOntologyBiologicalProcess | embryo development | EPHB2 FN1 PRICKLE1 EGLN1 LAMA1 PSMC3 CASP8 ITGA4 GFI1 ADCY9 RYR2 CTR9 MIB1 CXXC4 ATP11A EXOC3L2 RECK NOTCH2 VEGFA | 1.38e-04 | 1437 | 107 | 19 | GO:0009790 |
| GeneOntologyBiologicalProcess | embryo implantation | 1.51e-04 | 97 | 107 | 5 | GO:0007566 | |
| GeneOntologyBiologicalProcess | axonogenesis | EPHB2 FN1 PRICKLE1 CNTNAP1 LAMA1 LAMB1 ITGA4 PPP3CB PRKCQ NOTCH2 VEGFA | 1.73e-04 | 566 | 107 | 11 | GO:0007409 |
| GeneOntologyBiologicalProcess | muscle organ morphogenesis | 1.91e-04 | 102 | 107 | 5 | GO:0048644 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | EPHB2 DAB2IP FN1 PRICKLE1 TNC EGLN1 LAMA1 CASP8 SIRT6 RYR2 MIB1 PLAU RECK NOTCH2 SPINK5 VEGFA | 2.21e-04 | 1125 | 107 | 16 | GO:0035239 |
| GeneOntologyBiologicalProcess | cellular response to vitamin D | 2.23e-04 | 23 | 107 | 3 | GO:0071305 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell differentiation | 2.29e-04 | 106 | 107 | 5 | GO:0051149 | |
| GeneOntologyBiologicalProcess | lymph vessel morphogenesis | 2.54e-04 | 24 | 107 | 3 | GO:0036303 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | EPHB2 NRG1 IPO7 FN1 LAMA1 LAMB1 CASP8 PPARD SIRT6 GFI1 RASGRP1 PRKCH ATP11A PRDM16 NOTCH2 VEGFA | 2.59e-04 | 1141 | 107 | 16 | GO:0045597 |
| GeneOntologyBiologicalProcess | positive regulation of protein transport | 2.59e-04 | 319 | 107 | 8 | GO:0051222 | |
| GeneOntologyBiologicalProcess | negative regulation of autophagosome maturation | 2.64e-04 | 5 | 107 | 2 | GO:1901097 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | EGLN1 PSMC3 CASP8 ITGA4 ADCY9 CTR9 MIB1 ATP11A EXOC3L2 NOTCH2 VEGFA | 2.70e-04 | 596 | 107 | 11 | GO:0001701 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 2.86e-04 | 410 | 107 | 9 | GO:0031589 | |
| GeneOntologyBiologicalProcess | positive regulation of Ras protein signal transduction | 2.87e-04 | 25 | 107 | 3 | GO:0046579 | |
| GeneOntologyBiologicalProcess | negative regulation of protein serine/threonine kinase activity | 2.95e-04 | 112 | 107 | 5 | GO:0071901 | |
| GeneOntologyBiologicalProcess | negative regulation of proteolysis | 3.00e-04 | 326 | 107 | 8 | GO:0045861 | |
| GeneOntologyBiologicalProcess | tube development | EPHB2 DAB2IP FN1 SPINK2 ADAMTS2 PRICKLE1 TNC EGLN1 LAMA1 CASP8 SIRT6 RYR2 MIB1 PLAU RECK NOTCH2 SPINK5 VEGFA | 3.04e-04 | 1402 | 107 | 18 | GO:0035295 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | EPHB2 NRG1 FN1 TNC LAMA1 LAMB1 ITGA4 RASGRP1 PRKCD PRKCE PLAU PRKCQ SPINK5 VEGFA | 3.09e-04 | 927 | 107 | 14 | GO:0030155 |
| GeneOntologyBiologicalProcess | blood vessel development | EPHB2 DAB2IP FN1 PRICKLE1 EGLN1 LAMA1 CASP8 SIRT6 MIB1 PLAU RECK NOTCH2 SPINK5 VEGFA | 3.16e-04 | 929 | 107 | 14 | GO:0001568 |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 3.47e-04 | 421 | 107 | 9 | GO:0060562 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 3.53e-04 | 334 | 107 | 8 | GO:0051896 | |
| GeneOntologyBiologicalProcess | vascular endothelial growth factor receptor-2 signaling pathway | 3.95e-04 | 6 | 107 | 2 | GO:0036324 | |
| GeneOntologyBiologicalProcess | regulation of response to external stimulus | EPHB2 DAB2IP IPO5 NRG1 FN1 RHBDF2 TNC CASP8 PPARD GFI1 RASGRP1 PRKCD PRKCE PLAU NR1H2 SPINK5 VEGFA | 4.25e-04 | 1316 | 107 | 17 | GO:0032101 |
| GeneOntologyBiologicalProcess | gliogenesis | 4.40e-04 | 435 | 107 | 9 | GO:0042063 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 4.72e-04 | 124 | 107 | 5 | GO:0007229 | |
| GeneOntologyBiologicalProcess | regulation of immune response | EPHB2 DAB2IP IPO5 RHBDF2 CASP8 GFI1 SVEP1 RASGRP1 PPP3CB PRKCD PRKCE PRKCH NR1H2 PRKCQ SPINK5 | 4.76e-04 | 1085 | 107 | 15 | GO:0050776 |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | 4.94e-04 | 442 | 107 | 9 | GO:0050878 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | NRG1 PRICKLE1 TNC EGLN1 LAMA1 CASP8 SIRT6 RYR2 MIB1 KLK1 NOTCH2 VEGFA | 5.14e-04 | 750 | 107 | 12 | GO:0048729 |
| GeneOntologyBiologicalProcess | positive regulation of protein secretion | 5.27e-04 | 194 | 107 | 6 | GO:0050714 | |
| GeneOntologyBiologicalProcess | epithelium development | NRG1 IPO7 PRICKLE1 TNC LAMA1 CASP8 PPARD SIRT6 ITGA4 KANK2 GFI1 RYR2 MIB1 PRKCH USH2A NOTCH2 SPINK5 VEGFA | 5.31e-04 | 1469 | 107 | 18 | GO:0060429 |
| GeneOntologyBiologicalProcess | Ras protein signal transduction | 5.46e-04 | 128 | 107 | 5 | GO:0007265 | |
| GeneOntologyBiologicalProcess | cellular response to vitamin | 5.49e-04 | 31 | 107 | 3 | GO:0071295 | |
| GeneOntologyBiologicalProcess | left ventricular cardiac muscle tissue morphogenesis | 5.50e-04 | 7 | 107 | 2 | GO:0003220 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | EPHB2 DAB2IP FN1 SPINK2 PRICKLE1 EGLN1 CNTNAP1 CASP8 SIRT6 ITGB4 PPP3CB CTR9 MIB1 PLAU RECK NOTCH2 SPINK5 VEGFA | 5.94e-04 | 1483 | 107 | 18 | GO:0048646 |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | EPHB2 DAB2IP IPO7 PRICKLE1 PPARD GFI1 CTR9 MIB1 CTDP1 NR1H2 USH2A PRDM16 VEGFA | 6.00e-04 | 875 | 107 | 13 | GO:0045596 |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 6.03e-04 | 199 | 107 | 6 | GO:0051147 | |
| GeneOntologyBiologicalProcess | lymph vessel development | 6.03e-04 | 32 | 107 | 3 | GO:0001945 | |
| GeneOntologyBiologicalProcess | peripheral nervous system axon ensheathment | 6.61e-04 | 33 | 107 | 3 | GO:0032292 | |
| GeneOntologyBiologicalProcess | myelination in peripheral nervous system | 6.61e-04 | 33 | 107 | 3 | GO:0022011 | |
| GeneOntologyBiologicalProcess | positive regulation of epidermis development | 6.61e-04 | 33 | 107 | 3 | GO:0045684 | |
| GeneOntologyBiologicalProcess | embryonic organ development | EPHB2 PRICKLE1 EGLN1 CASP8 ITGA4 GFI1 RYR2 MIB1 NOTCH2 VEGFA | 6.77e-04 | 561 | 107 | 10 | GO:0048568 |
| GeneOntologyBiologicalProcess | negative regulation of molecular function | EPHB2 DAB2IP IPO5 IPO7 SPINK2 EGLN1 ITGA4 GFI1 PRKCD PRKCE PRKCH RECK SPINK5 VEGFA | 6.91e-04 | 1005 | 107 | 14 | GO:0044092 |
| GeneOntologyBiologicalProcess | regulation of defense response | EPHB2 DAB2IP IPO5 RHBDF2 TNC PENK CASP8 PPARD GFI1 RASGRP1 PRKCD PRKCE NR1H2 SPINK5 | 6.98e-04 | 1006 | 107 | 14 | GO:0031347 |
| GeneOntologyBiologicalProcess | filopodium assembly | 7.27e-04 | 78 | 107 | 4 | GO:0046847 | |
| GeneOntologyBiologicalProcess | negative regulation of serine-type peptidase activity | 7.31e-04 | 8 | 107 | 2 | GO:1902572 | |
| GeneOntologyBiologicalProcess | negative regulation of serine-type endopeptidase activity | 7.31e-04 | 8 | 107 | 2 | GO:1900004 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleocytoplasmic transport | 7.63e-04 | 79 | 107 | 4 | GO:0046824 | |
| GeneOntologyBiologicalProcess | regulation of protein import into nucleus | 8.38e-04 | 81 | 107 | 4 | GO:0042306 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 8.52e-04 | 382 | 107 | 8 | GO:0043491 | |
| GeneOntologyBiologicalProcess | regulation of proteasomal protein catabolic process | 8.59e-04 | 213 | 107 | 6 | GO:0061136 | |
| GeneOntologyBiologicalProcess | developmental growth | NRG1 FN1 PRICKLE1 TNC PPARD SIRT6 ITGA4 PPP3CB CTR9 CTDP1 PLAU NOTCH2 VEGFA | 8.70e-04 | 911 | 107 | 13 | GO:0048589 |
| GeneOntologyBiologicalProcess | regulation of miRNA transcription | 9.18e-04 | 83 | 107 | 4 | GO:1902893 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB2 DAB2IP FN1 PRICKLE1 CNTNAP1 LAMA1 LAMB1 ITGA4 PPP3CB PRKCQ NOTCH2 VEGFA | 9.24e-04 | 802 | 107 | 12 | GO:0048812 |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 9.50e-04 | 299 | 107 | 7 | GO:0060560 | |
| GeneOntologyBiologicalProcess | miRNA transcription | 9.60e-04 | 84 | 107 | 4 | GO:0061614 | |
| GeneOntologyBiologicalProcess | developmental cell growth | 9.88e-04 | 301 | 107 | 7 | GO:0048588 | |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | 9.89e-04 | 391 | 107 | 8 | GO:0051146 | |
| GeneOntologyBiologicalProcess | response to vitamin D | 1.00e-03 | 38 | 107 | 3 | GO:0033280 | |
| GeneOntologyBiologicalProcess | negative regulation of protein kinase activity | 1.04e-03 | 221 | 107 | 6 | GO:0006469 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | EPHB2 DAB2IP FN1 EGLN1 LAMA1 CASP8 SIRT6 PLAU RECK NOTCH2 SPINK5 VEGFA | 1.08e-03 | 817 | 107 | 12 | GO:0048514 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB2 DAB2IP FN1 PRICKLE1 CNTNAP1 LAMA1 LAMB1 ITGA4 PPP3CB PRKCQ NOTCH2 VEGFA | 1.11e-03 | 819 | 107 | 12 | GO:0120039 |
| GeneOntologyBiologicalProcess | angiogenesis | EPHB2 DAB2IP FN1 EGLN1 CASP8 SIRT6 PLAU RECK NOTCH2 SPINK5 VEGFA | 1.12e-03 | 708 | 107 | 11 | GO:0001525 |
| GeneOntologyBiologicalProcess | regulation of serine-type peptidase activity | 1.17e-03 | 10 | 107 | 2 | GO:1902571 | |
| GeneOntologyBiologicalProcess | regulation of serine-type endopeptidase activity | 1.17e-03 | 10 | 107 | 2 | GO:1900003 | |
| GeneOntologyBiologicalProcess | regulation of cold-induced thermogenesis | 1.18e-03 | 152 | 107 | 5 | GO:0120161 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | EPHB2 FN1 PRICKLE1 CASP8 ITGA4 GFI1 RYR2 CTR9 MIB1 RECK NOTCH2 | 1.19e-03 | 713 | 107 | 11 | GO:0048598 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB2 DAB2IP FN1 PRICKLE1 CNTNAP1 LAMA1 LAMB1 ITGA4 PPP3CB PRKCQ NOTCH2 VEGFA | 1.19e-03 | 826 | 107 | 12 | GO:0048858 |
| GeneOntologyBiologicalProcess | positive regulation of establishment of protein localization | 1.20e-03 | 403 | 107 | 8 | GO:1904951 | |
| GeneOntologyBiologicalProcess | cold-induced thermogenesis | 1.33e-03 | 156 | 107 | 5 | GO:0106106 | |
| GeneOntologyBiologicalProcess | neuron development | EPHB2 DAB2IP NRG1 FN1 PRICKLE1 TNC CNTNAP1 LAMA1 LAMB1 PRPH2 ITGA4 GFI1 PPP3CB PRKCQ RPGR NOTCH2 VEGFA | 1.38e-03 | 1463 | 107 | 17 | GO:0048666 |
| GeneOntologyBiologicalProcess | positive regulation of transport | EPHB2 IPO5 CACNA2D1 PPARD SIRT6 RYR2 ACSL1 PPP3CB MIB1 PRKCD PRKCE NR1H2 PRKCQ VEGFA | 1.39e-03 | 1081 | 107 | 14 | GO:0051050 |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 1.42e-03 | 11 | 107 | 2 | GO:0110011 | |
| GeneOntologyBiologicalProcess | nail development | 1.42e-03 | 11 | 107 | 2 | GO:0035878 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 5.96e-07 | 59 | 108 | 6 | GO:0098636 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 1.52e-06 | 17 | 108 | 4 | GO:0098637 | |
| GeneOntologyCellularComponent | basement membrane | 3.32e-06 | 122 | 108 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | laminin-1 complex | 7.91e-05 | 3 | 108 | 2 | GO:0005606 | |
| GeneOntologyCellularComponent | extracellular matrix | FN1 ADAMTS2 TNC LAMA1 LAMB1 ITGB4 SVEP1 LTBP2 USH2A MUC5AC FBN3 VEGFA | 1.47e-04 | 656 | 108 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | FN1 ADAMTS2 TNC LAMA1 LAMB1 ITGB4 SVEP1 LTBP2 USH2A MUC5AC FBN3 VEGFA | 1.52e-04 | 658 | 108 | 12 | GO:0030312 |
| MousePheno | abnormal myocardial trabeculae morphology | 3.07e-06 | 144 | 87 | 8 | MP:0002189 | |
| MousePheno | wavy tail | 4.59e-06 | 6 | 87 | 3 | MP:0013179 | |
| MousePheno | abnormal myocardium layer morphology | NRG1 FN1 PRICKLE1 EGLN1 CASP8 TBC1D25 CHD4 RYR2 CSDE1 ATP11A NOTCH2 VEGFA | 9.25e-06 | 414 | 87 | 12 | MP:0005329 |
| MousePheno | abnormal heart layer morphology | NRG1 FN1 PRICKLE1 EGLN1 CASP8 TBC1D25 CHD4 RYR2 CSDE1 ATP11A NOTCH2 VEGFA | 1.12e-05 | 422 | 87 | 12 | MP:0010545 |
| MousePheno | abnormal cardiac muscle tissue morphology | NRG1 FN1 PRICKLE1 EGLN1 CASP8 TBC1D25 CHD4 RYR2 CSDE1 ATP11A NOTCH2 VEGFA | 4.79e-05 | 489 | 87 | 12 | MP:0010630 |
| MousePheno | decreased heart ventricle muscle contractility | 5.34e-05 | 107 | 87 | 6 | MP:0005598 | |
| MousePheno | abnormal extraembryonic tissue physiology | 5.45e-05 | 345 | 87 | 10 | MP:0004264 | |
| MousePheno | decreased heart left ventricle muscle contractility | 5.51e-05 | 66 | 87 | 5 | MP:0031633 | |
| MousePheno | abnormal response of heart to induced stress | 5.92e-05 | 109 | 87 | 6 | MP:0004484 | |
| MousePheno | abnormal response to injury | FN1 RHBDF2 EGLN1 PENK TBC1D25 PPARD RYR2 PPP3CB ITGB1BP2 PRKCD PRKCE PRKCH PLAU | 9.12e-05 | 607 | 87 | 13 | MP:0005164 |
| MousePheno | abnormal placenta morphology | FN1 EGLN1 LAMA1 PPARD ITGA4 ADCY9 CSDE1 CXXC4 ATP11A EXOC3L2 NOTCH2 VEGFA | 9.46e-05 | 525 | 87 | 12 | MP:0001711 |
| MousePheno | abnormal heart development | 1.02e-04 | 372 | 87 | 10 | MP:0000267 | |
| MousePheno | abnormal cardiovascular development | NRG1 FN1 PRICKLE1 EGLN1 CASP8 CHD4 ITGA4 ITGB4 ADCY9 RYR2 CSDE1 MIB1 ATP11A RECK VEGFA | 1.15e-04 | 802 | 87 | 15 | MP:0002925 |
| MousePheno | abnormal extraembryonic tissue morphology | FN1 EGLN1 LAMA1 LAMB1 CASP8 PPARD ITGA4 ADCY9 CSDE1 MIB1 CXXC4 ATP11A EXOC3L2 PRDM15 NOTCH2 VEGFA | 1.33e-04 | 908 | 87 | 16 | MP:0002086 |
| MousePheno | thin myocardium compact layer | 1.87e-04 | 46 | 87 | 4 | MP:0004057 | |
| MousePheno | abnormal placenta labyrinth morphology | 2.04e-04 | 194 | 87 | 7 | MP:0001716 | |
| MousePheno | abnormal cardiac jelly morphology | 2.28e-04 | 4 | 87 | 2 | MP:0009382 | |
| MousePheno | abnormal heart ventricle morphology | NRG1 PRICKLE1 EGLN1 CASP8 CHD4 ADCY9 RYR2 CSDE1 PPP3CB ATP11A KLK1 PRDM16 PRDM15 VEGFA | 3.61e-04 | 793 | 87 | 14 | MP:0005294 |
| Domain | EGF_1 | NRG1 FN1 TNC CNTNAP1 LAMA1 LAMB1 ITGB4 SVEP1 MEP1A PLAU LTBP2 USH2A FBN3 NOTCH2 | 2.44e-10 | 255 | 108 | 14 | PS00022 |
| Domain | Prot_kin_PKC_delta | 1.06e-09 | 4 | 108 | 4 | IPR014376 | |
| Domain | DAG/PE-bd | 1.64e-09 | 21 | 108 | 6 | IPR020454 | |
| Domain | EGF-like_CS | NRG1 FN1 TNC CNTNAP1 LAMA1 LAMB1 ITGB4 SVEP1 MEP1A PLAU LTBP2 FBN3 NOTCH2 | 3.64e-09 | 261 | 108 | 13 | IPR013032 |
| Domain | EGF_2 | EPHB2 NRG1 TNC CNTNAP1 LAMA1 LAMB1 ITGB4 SVEP1 MEP1A PLAU LTBP2 FBN3 NOTCH2 | 4.37e-09 | 265 | 108 | 13 | PS01186 |
| Domain | EGF | NRG1 TNC CNTNAP1 LAMA1 LAMB1 SVEP1 MEP1A PLAU LTBP2 FBN3 NOTCH2 | 1.17e-07 | 235 | 108 | 11 | SM00181 |
| Domain | EGF-like_dom | NRG1 TNC CNTNAP1 LAMA1 LAMB1 SVEP1 MEP1A PLAU LTBP2 FBN3 NOTCH2 | 2.10e-07 | 249 | 108 | 11 | IPR000742 |
| Domain | Growth_fac_rcpt_ | 3.03e-07 | 156 | 108 | 9 | IPR009030 | |
| Domain | EGF | 6.87e-07 | 126 | 108 | 8 | PF00008 | |
| Domain | C1_1 | 9.28e-07 | 57 | 108 | 6 | PF00130 | |
| Domain | ZF_DAG_PE_1 | 1.86e-06 | 64 | 108 | 6 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.86e-06 | 64 | 108 | 6 | PS50081 | |
| Domain | C1 | 2.04e-06 | 65 | 108 | 6 | SM00109 | |
| Domain | Pkinase_C | 2.22e-06 | 37 | 108 | 5 | IPR017892 | |
| Domain | PE/DAG-bd | 2.23e-06 | 66 | 108 | 6 | IPR002219 | |
| Domain | Pkinase_C | 4.23e-06 | 42 | 108 | 5 | PF00433 | |
| Domain | EGF_3 | 9.00e-06 | 235 | 108 | 9 | PS50026 | |
| Domain | AGC-kinase_C | 1.78e-05 | 56 | 108 | 5 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 1.78e-05 | 56 | 108 | 5 | PS51285 | |
| Domain | S_TK_X | 1.78e-05 | 56 | 108 | 5 | SM00133 | |
| Domain | ConA-like_dom | 4.05e-05 | 219 | 108 | 8 | IPR013320 | |
| Domain | IMPORTIN_B_NT | 6.53e-05 | 14 | 108 | 3 | PS50166 | |
| Domain | Cse1 | 9.90e-05 | 3 | 108 | 2 | PF08506 | |
| Domain | Cse1 | 9.90e-05 | 3 | 108 | 2 | IPR013713 | |
| Domain | Laminin_N | 9.97e-05 | 16 | 108 | 3 | IPR008211 | |
| Domain | LamNT | 9.97e-05 | 16 | 108 | 3 | SM00136 | |
| Domain | LAMININ_NTER | 9.97e-05 | 16 | 108 | 3 | PS51117 | |
| Domain | Laminin_N | 9.97e-05 | 16 | 108 | 3 | PF00055 | |
| Domain | Importin-beta_N | 1.21e-04 | 17 | 108 | 3 | IPR001494 | |
| Domain | KAZAL_1 | 1.44e-04 | 18 | 108 | 3 | PS00282 | |
| Domain | - | ZNF438 ZNF142 ZNF155 ZNF225 GFI1 ZNF440 ZNF263 ZNF684 ZNF565 ZBTB11 PRDM16 PRDM15 ZNF654 | 1.49e-04 | 679 | 108 | 13 | 3.30.160.60 |
| Domain | C2 | 1.76e-04 | 142 | 108 | 6 | PS50004 | |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF438 ZNF142 ZNF155 ZNF225 GFI1 ZNF440 ZNF263 ZNF684 ZNF565 ZBTB11 PRDM16 PRDM15 ZNF654 | 1.84e-04 | 694 | 108 | 13 | IPR013087 |
| Domain | LamGL | 1.97e-04 | 4 | 108 | 2 | SM00560 | |
| Domain | LamG-like | 1.97e-04 | 4 | 108 | 2 | IPR006558 | |
| Domain | - | 2.20e-04 | 148 | 108 | 6 | 2.60.40.150 | |
| Domain | - | 2.26e-04 | 95 | 108 | 5 | 2.60.120.200 | |
| Domain | C2_dom | 3.82e-04 | 164 | 108 | 6 | IPR000008 | |
| Domain | Ephrin_rec_like | 3.94e-04 | 25 | 108 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 3.94e-04 | 25 | 108 | 3 | IPR011641 | |
| Domain | EGF_extracell | 4.02e-04 | 60 | 108 | 4 | IPR013111 | |
| Domain | EGF_2 | 4.02e-04 | 60 | 108 | 4 | PF07974 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF438 ZNF142 ZNF155 ZNF225 GFI1 ZNF440 ZNF263 ZNF684 ZNF565 ZBTB11 PRDM16 PRDM15 ZNF654 | 5.31e-04 | 775 | 108 | 13 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF438 ZNF142 ZNF155 ZNF225 GFI1 ZNF440 ZNF263 ZNF684 ZNF565 ZBTB11 PRDM16 PRDM15 ZNF654 | 5.44e-04 | 777 | 108 | 13 | PS00028 |
| Domain | hEGF | 5.54e-04 | 28 | 108 | 3 | PF12661 | |
| Domain | zf-C2H2 | ZNF438 ZNF142 ZNF155 ZNF225 GFI1 ZNF440 ZNF263 ZNF684 ZNF565 ZBTB11 PRDM16 PRDM15 | 6.66e-04 | 693 | 108 | 12 | PF00096 |
| Domain | EGF_LAM_2 | 6.81e-04 | 30 | 108 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 6.81e-04 | 30 | 108 | 3 | PS01248 | |
| Domain | Znf_C2H2-like | ZNF438 ZNF142 ZNF155 ZNF225 GFI1 ZNF440 ZNF263 ZNF684 ZNF565 ZBTB11 PRDM16 PRDM15 ZNF654 | 6.82e-04 | 796 | 108 | 13 | IPR015880 |
| Domain | TB | 6.83e-04 | 7 | 108 | 2 | PF00683 | |
| Domain | Notch_dom | 6.83e-04 | 7 | 108 | 2 | IPR000800 | |
| Domain | Notch | 6.83e-04 | 7 | 108 | 2 | PF00066 | |
| Domain | NL | 6.83e-04 | 7 | 108 | 2 | SM00004 | |
| Domain | Znf_C2H2 | ZNF438 ZNF142 ZNF155 ZNF225 GFI1 ZNF440 ZNF263 ZNF684 ZNF565 ZBTB11 PRDM16 PRDM15 ZNF654 | 7.56e-04 | 805 | 108 | 13 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF438 ZNF142 ZNF155 ZNF225 GFI1 ZNF440 ZNF263 ZNF684 ZNF565 ZBTB11 PRDM16 PRDM15 ZNF654 | 7.83e-04 | 808 | 108 | 13 | SM00355 |
| Domain | - | 9.07e-04 | 8 | 108 | 2 | 3.90.290.10 | |
| Domain | EGF_Lam | 1.08e-03 | 35 | 108 | 3 | SM00180 | |
| Domain | Laminin_EGF | 1.08e-03 | 35 | 108 | 3 | PF00053 | |
| Domain | TB_dom | 1.16e-03 | 9 | 108 | 2 | IPR017878 | |
| Domain | TB | 1.16e-03 | 9 | 108 | 2 | PS51364 | |
| Domain | C2 | 1.20e-03 | 137 | 108 | 5 | SM00239 | |
| Domain | LAM_G_DOMAIN | 1.37e-03 | 38 | 108 | 3 | PS50025 | |
| Domain | Laminin_EGF | 1.37e-03 | 38 | 108 | 3 | IPR002049 | |
| Domain | EGF_CA | 1.56e-03 | 86 | 108 | 4 | PF07645 | |
| Domain | Laminin_G_2 | 1.59e-03 | 40 | 108 | 3 | PF02210 | |
| Domain | Ephrin_rec_like | 1.76e-03 | 11 | 108 | 2 | PF07699 | |
| Domain | LamG | 2.10e-03 | 44 | 108 | 3 | SM00282 | |
| Domain | Galactose-bd-like | 2.16e-03 | 94 | 108 | 4 | IPR008979 | |
| Domain | zf-C2H2_6 | 2.33e-03 | 314 | 108 | 7 | PF13912 | |
| Domain | KAZAL | 2.38e-03 | 46 | 108 | 3 | SM00280 | |
| Domain | EGF_Ca-bd_CS | 2.43e-03 | 97 | 108 | 4 | IPR018097 | |
| Domain | fn3 | 2.51e-03 | 162 | 108 | 5 | PF00041 | |
| Domain | ZINC_PROTEASE | 2.52e-03 | 98 | 108 | 4 | PS00142 | |
| Domain | EGF_CA | 2.61e-03 | 99 | 108 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.71e-03 | 100 | 108 | 4 | PS00010 | |
| Domain | KAZAL_2 | 3.03e-03 | 50 | 108 | 3 | PS51465 | |
| Domain | Kazal_dom | 3.20e-03 | 51 | 108 | 3 | IPR002350 | |
| Domain | IBN_N | 3.31e-03 | 15 | 108 | 2 | PF03810 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.34e-03 | 106 | 108 | 4 | IPR000152 | |
| Domain | IBN_N | 3.77e-03 | 16 | 108 | 2 | SM00913 | |
| Domain | FN3 | 4.43e-03 | 185 | 108 | 5 | SM00060 | |
| Domain | Laminin_G | 4.61e-03 | 58 | 108 | 3 | IPR001791 | |
| Domain | EGF_CA | 5.51e-03 | 122 | 108 | 4 | SM00179 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.96e-07 | 66 | 90 | 7 | M18 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 5.66e-07 | 48 | 90 | 6 | M10775 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 6.85e-07 | 27 | 90 | 5 | M12123 | |
| Pathway | PID_NFAT_3PATHWAY | 1.03e-06 | 53 | 90 | 6 | M113 | |
| Pathway | WP_WNT_SIGNALING | 2.40e-06 | 61 | 90 | 6 | MM15893 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 2.90e-06 | 63 | 90 | 6 | M8 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 3.61e-06 | 101 | 90 | 7 | M39387 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 3.61e-06 | 101 | 90 | 7 | MM15829 | |
| Pathway | WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY | 4.60e-06 | 39 | 90 | 5 | M39905 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 7.54e-06 | 43 | 90 | 5 | M53 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 1.06e-05 | 46 | 90 | 5 | M19118 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 1.06e-05 | 46 | 90 | 5 | MM1428 | |
| Pathway | WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION | 1.06e-05 | 46 | 90 | 5 | M46450 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.56e-05 | 84 | 90 | 6 | M7098 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.77e-05 | 25 | 90 | 4 | MM14511 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 2.32e-05 | 90 | 90 | 6 | MM15882 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 2.47e-05 | 91 | 90 | 6 | M39426 | |
| Pathway | PID_TXA2PATHWAY | 2.80e-05 | 56 | 90 | 5 | M99 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.62e-05 | 59 | 90 | 5 | M27218 | |
| Pathway | WP_FOCAL_ADHESION | 3.95e-05 | 199 | 90 | 8 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.95e-05 | 199 | 90 | 8 | M7253 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 4.00e-05 | 11 | 90 | 3 | M158 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 4.21e-05 | 147 | 90 | 7 | MM15854 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 4.87e-05 | 32 | 90 | 4 | M165 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 5.00e-05 | 151 | 90 | 7 | M39329 | |
| Pathway | PID_SYNDECAN_2_PATHWAY | 5.52e-05 | 33 | 90 | 4 | M240 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 5.52e-05 | 33 | 90 | 4 | M39503 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 5.67e-05 | 154 | 90 | 7 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 6.15e-05 | 156 | 90 | 7 | M39475 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 8.71e-05 | 14 | 90 | 3 | MM14531 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 9.22e-05 | 115 | 90 | 6 | M9387 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 1.06e-04 | 118 | 90 | 6 | M39852 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 1.15e-04 | 75 | 90 | 5 | M39568 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.24e-04 | 300 | 90 | 9 | M610 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 1.31e-04 | 41 | 90 | 4 | M512 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 1.40e-04 | 124 | 90 | 6 | M27285 | |
| Pathway | PID_INTEGRIN5_PATHWAY | 1.60e-04 | 17 | 90 | 3 | M212 | |
| Pathway | WP_FOCAL_ADHESION | 1.91e-04 | 187 | 90 | 7 | MM15913 | |
| Pathway | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | 2.34e-04 | 257 | 90 | 8 | MM15454 | |
| Pathway | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | 2.59e-04 | 261 | 90 | 8 | M1077 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 2.72e-04 | 90 | 90 | 5 | M835 | |
| Pathway | WP_BURN_WOUND_HEALING | 3.08e-04 | 21 | 90 | 3 | MM15978 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 3.55e-04 | 22 | 90 | 3 | M26929 | |
| Pathway | WP_CANCER_PATHWAYS | FN1 EGLN1 LAMA1 LAMB1 CASP8 PPARD ADCY9 RASGRP1 PRKCG NOTCH2 VEGFA | 3.73e-04 | 507 | 90 | 11 | M48302 |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 4.04e-04 | 98 | 90 | 5 | M39830 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 4.06e-04 | 23 | 90 | 3 | M47537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 4.06e-04 | 23 | 90 | 3 | M47720 | |
| Pathway | PID_INTEGRIN_A9B1_PATHWAY | 5.23e-04 | 25 | 90 | 3 | M118 | |
| Pathway | WP_MAPK_SIGNALING_PATHWAY | 5.52e-04 | 160 | 90 | 6 | MM15990 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 5.88e-04 | 26 | 90 | 3 | MM14495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 5.88e-04 | 26 | 90 | 3 | M47719 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 6.59e-04 | 27 | 90 | 3 | M27217 | |
| Pathway | PID_GLYPICAN_1PATHWAY | 6.59e-04 | 27 | 90 | 3 | M33 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 7.34e-04 | 28 | 90 | 3 | M47655 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 7.74e-04 | 113 | 90 | 5 | M39669 | |
| Pathway | WP_ONCOSTATIN_M_SIGNALING | 7.81e-04 | 65 | 90 | 4 | M39562 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 8.28e-04 | 66 | 90 | 4 | MM15925 | |
| Pathway | WP_GASTRIN_SIGNALING | 8.38e-04 | 115 | 90 | 5 | M39866 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 9.02e-04 | 30 | 90 | 3 | M27772 | |
| Pathway | PID_RAS_PATHWAY | 9.02e-04 | 30 | 90 | 3 | M269 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 9.02e-04 | 30 | 90 | 3 | M27216 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 9.02e-04 | 30 | 90 | 3 | M47724 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 9.02e-04 | 30 | 90 | 3 | M47718 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 1.10e-03 | 325 | 90 | 8 | M12868 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 1.14e-03 | 252 | 90 | 7 | MM15585 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 1.27e-03 | 74 | 90 | 4 | M16376 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 1.27e-03 | 74 | 90 | 4 | M39462 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.30e-03 | 258 | 90 | 7 | MM14572 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.40e-03 | 76 | 90 | 4 | M27219 | |
| Pathway | KEGG_TIGHT_JUNCTION | 1.55e-03 | 132 | 90 | 5 | M11355 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.67e-03 | 37 | 90 | 3 | M27134 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | 1.67e-03 | 37 | 90 | 3 | MM14488 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.67e-03 | 37 | 90 | 3 | M749 | |
| Pathway | WP_OREXIN_RECEPTOR_PATHWAY | 1.75e-03 | 200 | 90 | 6 | M48048 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | 1.81e-03 | 38 | 90 | 3 | M495 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 1.94e-03 | 83 | 90 | 4 | M8728 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 1.94e-03 | 83 | 90 | 4 | M39637 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.95e-03 | 39 | 90 | 3 | MM14496 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 2.01e-03 | 140 | 90 | 5 | M27484 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.25e-03 | 41 | 90 | 3 | M27778 | |
| Pathway | BIOCARTA_PRION_PATHWAY | 2.55e-03 | 12 | 90 | 2 | M22020 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 2.61e-03 | 90 | 90 | 4 | M6467 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.76e-03 | 44 | 90 | 3 | M26969 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 2.76e-03 | 44 | 90 | 3 | MM14520 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 2.79e-03 | 151 | 90 | 5 | M19428 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_SIGNALING | 2.94e-03 | 93 | 90 | 4 | MM15204 | |
| Pathway | REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM | 3.00e-03 | 13 | 90 | 2 | MM14821 | |
| Pathway | REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM | 3.00e-03 | 13 | 90 | 2 | M27114 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 3.00e-03 | 13 | 90 | 2 | MM15171 | |
| Pathway | WP_HYPOXIADEPENDENT_DIFFERENTIATION_OF_MYOBLASTS | 3.00e-03 | 13 | 90 | 2 | MM15894 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 3.13e-03 | 46 | 90 | 3 | M239 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 3.17e-03 | 302 | 90 | 7 | M39719 | |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 3.30e-03 | 96 | 90 | 4 | M16121 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 3.30e-03 | 96 | 90 | 4 | M39834 | |
| Pathway | REACTOME_HEMOSTASIS | 3.42e-03 | 571 | 90 | 10 | MM14472 | |
| Pubmed | 1.46e-11 | 8 | 108 | 5 | 7606770 | ||
| Pubmed | 3.28e-11 | 9 | 108 | 5 | 8473314 | ||
| Pubmed | 3.28e-11 | 9 | 108 | 5 | 7850771 | ||
| Pubmed | Regulation of HIV-1 gag protein subcellular targeting by protein kinase C. | 3.28e-11 | 9 | 108 | 5 | 7876252 | |
| Pubmed | 3.28e-11 | 9 | 108 | 5 | 8206685 | ||
| Pubmed | Human immunodeficiency virus induces phosphorylation of its cell surface receptor. | 6.55e-11 | 10 | 108 | 5 | 3259291 | |
| Pubmed | 6.55e-11 | 10 | 108 | 5 | 1970444 | ||
| Pubmed | Effect of serine and tyrosine phosphorylation on retroviral proteinase substrates. | 6.55e-11 | 10 | 108 | 5 | 10491200 | |
| Pubmed | 6.55e-11 | 10 | 108 | 5 | 2139676 | ||
| Pubmed | Unraveling the hidden role of a uORF-encoded peptide as a kinase inhibitor of PKCs. | 8.79e-11 | 4 | 108 | 4 | 34593629 | |
| Pubmed | 1.20e-10 | 11 | 108 | 5 | 14613966 | ||
| Pubmed | IL-16- and other CD4 ligand-induced migration is dependent upon protein kinase C. | 1.20e-10 | 11 | 108 | 5 | 8599832 | |
| Pubmed | Trans-activation of HIV-1 LTR-directed gene expression by tat requires protein kinase C. | 1.20e-10 | 11 | 108 | 5 | 2182321 | |
| Pubmed | 1.20e-10 | 11 | 108 | 5 | 8914829 | ||
| Pubmed | Expression profile of protein kinase C isozymes in preimplantation mouse development. | 1.20e-10 | 11 | 108 | 5 | 16183862 | |
| Pubmed | 2.05e-10 | 12 | 108 | 5 | 11919157 | ||
| Pubmed | Involvement of protein kinase C in HIV-1 gp120-induced apoptosis in primary endothelium. | 2.05e-10 | 12 | 108 | 5 | 11141237 | |
| Pubmed | HIV-1 Tat and AIDS-associated cancer: targeting the cellular anti-cancer barrier? | 2.05e-10 | 12 | 108 | 5 | 18577246 | |
| Pubmed | 2.05e-10 | 12 | 108 | 5 | 19363595 | ||
| Pubmed | HIV-1 reverse transcriptase is phosphorylated in vitro and in a cellular system. | 3.32e-10 | 13 | 108 | 5 | 10641798 | |
| Pubmed | 3.32e-10 | 13 | 108 | 5 | 8948582 | ||
| Pubmed | HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells. | 5.15e-10 | 14 | 108 | 5 | 7642615 | |
| Pubmed | 7.70e-10 | 15 | 108 | 5 | 8627654 | ||
| Pubmed | HIV envelope gp120 activates human arterial smooth muscle cells. | 7.70e-10 | 15 | 108 | 5 | 11504923 | |
| Pubmed | 1.12e-09 | 16 | 108 | 5 | 1832084 | ||
| Pubmed | 1.12e-09 | 16 | 108 | 5 | 11833470 | ||
| Pubmed | Protein kinase C isoform expression and activity in the mouse heart. | 1.31e-09 | 6 | 108 | 4 | 11668067 | |
| Pubmed | Signaling pathways triggered by HIV-1 Tat in human monocytes to induce TNF-alpha. | 1.98e-09 | 38 | 108 | 6 | 12482669 | |
| Pubmed | 3.93e-09 | 20 | 108 | 5 | 11044099 | ||
| Pubmed | 5.14e-09 | 21 | 108 | 5 | 9446795 | ||
| Pubmed | 5.14e-09 | 21 | 108 | 5 | 22114277 | ||
| Pubmed | 5.14e-09 | 21 | 108 | 5 | 9671211 | ||
| Pubmed | 6.10e-09 | 8 | 108 | 4 | 15894802 | ||
| Pubmed | 6.64e-09 | 22 | 108 | 5 | 9151826 | ||
| Pubmed | 6.64e-09 | 22 | 108 | 5 | 11154208 | ||
| Pubmed | 1.07e-08 | 24 | 108 | 5 | 10843712 | ||
| Pubmed | 1.09e-08 | 9 | 108 | 4 | 11700305 | ||
| Pubmed | 1.09e-08 | 9 | 108 | 4 | 9882526 | ||
| Pubmed | 1.09e-08 | 9 | 108 | 4 | 17203073 | ||
| Pubmed | 1.09e-08 | 9 | 108 | 4 | 22688677 | ||
| Pubmed | Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120. | 1.33e-08 | 25 | 108 | 5 | 15689238 | |
| Pubmed | 2.01e-08 | 27 | 108 | 5 | 21651489 | ||
| Pubmed | 2.01e-08 | 27 | 108 | 5 | 20336759 | ||
| Pubmed | 6.15e-08 | 13 | 108 | 4 | 12761849 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 8.73e-08 | 248 | 108 | 9 | 24006456 | |
| Pubmed | A cascade of protein kinase C isozymes promotes cytoskeletal polarization in T cells. | 1.16e-07 | 4 | 108 | 3 | 21602810 | |
| Pubmed | Protein kinase Cδ mediates the activation of protein kinase D2 in platelets. | 1.16e-07 | 4 | 108 | 3 | 21736870 | |
| Pubmed | Protein kinase C Theta inhibits insulin signaling by phosphorylating IRS1 at Ser(1101). | 1.16e-07 | 4 | 108 | 3 | 15364919 | |
| Pubmed | Dual Regulation of Spine-Specific and Synapse-to-Nucleus Signaling by PKCδ during Plasticity. | 1.16e-07 | 4 | 108 | 3 | 37277178 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 8670164 | ||
| Pubmed | TGF-beta-1 up-regulates extra-cellular matrix production in mouse hepatoblasts. | 2.60e-07 | 18 | 108 | 4 | 23041440 | |
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 2.60e-07 | 18 | 108 | 4 | 39040056 | |
| Pubmed | Protein kinase C activity regulates the onset of anaphase I in mouse oocytes. | 2.90e-07 | 5 | 108 | 3 | 15229137 | |
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 17904606 | ||
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 24863469 | ||
| Pubmed | The use of fluorescent phorbol esters in studies of protein kinase C-membrane interactions. | 5.78e-07 | 6 | 108 | 3 | 12093536 | |
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 12783114 | ||
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 20874775 | ||
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 8621384 | ||
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 15632189 | ||
| Pubmed | Protein kinase C-theta is specifically localized on centrosomes and kinetochores in mitotic cells. | 5.78e-07 | 6 | 108 | 3 | 9854032 | |
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 10879655 | ||
| Pubmed | An immunohistochemical study of protein kinase C distribution in fetal mouse vertebral column. | 5.78e-07 | 6 | 108 | 3 | 7985811 | |
| Pubmed | 8.86e-07 | 56 | 108 | 5 | 23934736 | ||
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 11682607 | ||
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 9857183 | ||
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 15381704 | ||
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 10433554 | ||
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 7588787 | ||
| Pubmed | PC phosphorylation increases the ability of AFAP-110 to cross-link actin filaments. | 1.61e-06 | 8 | 108 | 3 | 12134071 | |
| Pubmed | 1.61e-06 | 8 | 108 | 3 | 14699138 | ||
| Pubmed | 1.61e-06 | 8 | 108 | 3 | 19633172 | ||
| Pubmed | 1.61e-06 | 8 | 108 | 3 | 27114554 | ||
| Pubmed | 1.61e-06 | 8 | 108 | 3 | 8922669 | ||
| Pubmed | Ca2+/calmodulin-dependent protein kinase II regulates Tiam1 by reversible protein phosphorylation. | 1.61e-06 | 8 | 108 | 3 | 10212259 | |
| Pubmed | Essential roles of Meltrin beta (ADAM19) in heart development. | 1.61e-06 | 8 | 108 | 3 | 14975714 | |
| Pubmed | 1.97e-06 | 29 | 108 | 4 | 19094228 | ||
| Pubmed | 2.26e-06 | 30 | 108 | 4 | 18055048 | ||
| Pubmed | 2.41e-06 | 9 | 108 | 3 | 9827803 | ||
| Pubmed | 2.41e-06 | 9 | 108 | 3 | 10391924 | ||
| Pubmed | 2.96e-06 | 32 | 108 | 4 | 23154389 | ||
| Pubmed | Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtkγ. | 3.44e-06 | 10 | 108 | 3 | 21482705 | |
| Pubmed | 3.44e-06 | 10 | 108 | 3 | 11884598 | ||
| Pubmed | 4.41e-06 | 210 | 108 | 7 | 16537572 | ||
| Pubmed | Expression and roles of connective tissue growth factor in Meckel's cartilage development. | 4.72e-06 | 11 | 108 | 3 | 15305294 | |
| Pubmed | 4.72e-06 | 11 | 108 | 3 | 24348274 | ||
| Pubmed | CHD4-regulated plasmin activation impacts lymphovenous hemostasis and hepatic vascular integrity. | 6.28e-06 | 12 | 108 | 3 | 27140400 | |
| Pubmed | 7.37e-06 | 40 | 108 | 4 | 38418556 | ||
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 8.14e-06 | 13 | 108 | 3 | 9833687 | |
| Pubmed | 8.14e-06 | 13 | 108 | 3 | 33144400 | ||
| Pubmed | Common variants of NRG1 and ITGB4 confer risk of Hirschsprung disease in Han Chinese population. | 9.55e-06 | 2 | 108 | 2 | 32418639 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 19248786 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 28986537 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11606660 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 23313574 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12209601 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 14645153 | ||
| Pubmed | Binding of tenascin-C to soluble fibronectin and matrix fibrils. | 9.55e-06 | 2 | 108 | 2 | 7499434 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 35141985 | ||
| Pubmed | Alpha4beta1 integrin acts as a cell receptor for murine polyomavirus at the postattachment level. | 9.55e-06 | 2 | 108 | 2 | 12634351 | |
| Interaction | IGFL3 interactions | 2.33e-06 | 75 | 103 | 6 | int:IGFL3 | |
| Interaction | PDLIM5 interactions | 1.11e-05 | 273 | 103 | 9 | int:PDLIM5 | |
| Interaction | SMAD9 interactions | 1.36e-05 | 153 | 103 | 7 | int:SMAD9 | |
| Interaction | PSEN1 interactions | 2.17e-05 | 227 | 103 | 8 | int:PSEN1 | |
| Interaction | MSN interactions | 4.94e-05 | 330 | 103 | 9 | int:MSN | |
| Interaction | GRM5 interactions | 6.81e-05 | 43 | 103 | 4 | int:GRM5 | |
| Interaction | MEP1B interactions | 6.92e-05 | 16 | 103 | 3 | int:MEP1B | |
| Interaction | ACSL6 interactions | 6.92e-05 | 16 | 103 | 3 | int:ACSL6 | |
| Interaction | FBXW10B interactions | 7.73e-05 | 3 | 103 | 2 | int:FBXW10B | |
| Interaction | H3P16 interactions | 7.73e-05 | 3 | 103 | 2 | int:H3P16 | |
| Interaction | SDC2 interactions | 9.34e-05 | 143 | 103 | 6 | int:SDC2 | |
| Interaction | SLURP1 interactions | 9.70e-05 | 144 | 103 | 6 | int:SLURP1 | |
| Interaction | RASGRP3 interactions | 1.00e-04 | 18 | 103 | 3 | int:RASGRP3 | |
| Interaction | CHAT interactions | 1.00e-04 | 18 | 103 | 3 | int:CHAT | |
| Cytoband | 7q21.12 | 1.52e-04 | 8 | 108 | 2 | 7q21.12 | |
| Cytoband | 1p22 | 1.01e-03 | 20 | 108 | 2 | 1p22 | |
| Cytoband | 11p15.4 | 1.32e-03 | 200 | 108 | 4 | 11p15.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 2.23e-03 | 564 | 108 | 6 | chr11p15 | |
| Cytoband | 17q23.2 | 2.76e-03 | 33 | 108 | 2 | 17q23.2 | |
| Cytoband | 10q22.2 | 4.23e-03 | 41 | 108 | 2 | 10q22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q33 | 4.31e-03 | 138 | 108 | 3 | chr9q33 | |
| GeneFamily | C2 domain containing protein kinases | 5.35e-10 | 10 | 86 | 5 | 835 | |
| GeneFamily | Armadillo repeat containing|Importins | 8.05e-05 | 18 | 86 | 3 | 596 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF438 ZNF142 ZNF155 ZNF225 GFI1 ZNF440 ZNF263 ZNF684 ZNF565 ZBTB11 PRDM16 PRDM15 | 1.45e-04 | 718 | 86 | 12 | 28 |
| GeneFamily | Serine peptidase inhibitors, Kazal type | 9.82e-04 | 10 | 86 | 2 | 740 | |
| GeneFamily | Fibronectin type III domain containing | 9.97e-04 | 160 | 86 | 5 | 555 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 1.20e-03 | 11 | 86 | 2 | 559 | |
| GeneFamily | Laminin subunits | 1.43e-03 | 12 | 86 | 2 | 626 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 2.90e-03 | 17 | 86 | 2 | 1197 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.47e-06 | 196 | 107 | 8 | M3008 | |
| Coexpression | NABA_MATRISOME | NRG1 FN1 ADAMTS2 TNC EGLN1 LAMA1 LAMB1 SVEP1 MEP1A PAPPA PLAU LTBP2 USH2A MUC5AC FBN3 VEGFA | 4.14e-06 | 1026 | 107 | 16 | M5889 |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 5.76e-06 | 29 | 107 | 4 | MM17055 | |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_UP | 7.80e-06 | 175 | 107 | 7 | M6723 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C4 | 1.07e-05 | 11 | 107 | 3 | M566 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 1.25e-05 | 35 | 107 | 4 | MM17054 | |
| Coexpression | VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 | 1.56e-05 | 37 | 107 | 4 | M16643 | |
| Coexpression | NABA_CORE_MATRISOME | 1.76e-05 | 275 | 107 | 8 | M5884 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP | 1.86e-05 | 200 | 107 | 7 | M7256 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | ZNF142 FN1 CASP8 CHD4 CHD1L PPARD ADCY9 PRODH2 KLHL9 CTDP1 RPGR | 2.10e-05 | 567 | 107 | 11 | M16909 |
| Coexpression | BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN | 3.75e-05 | 46 | 107 | 4 | M6679 | |
| Coexpression | NABA_MATRISOME | NRG1 FN1 ADAMTS2 TNC EGLN1 LAMA1 LAMB1 SVEP1 MEP1A PAPPA PLAU LTBP2 MUC5AC VEGFA | 6.18e-05 | 1008 | 107 | 14 | MM17056 |
| Coexpression | ZHU_SKIL_TARGETS_UP | 7.17e-05 | 20 | 107 | 3 | M2273 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | TRHDE NRG1 PRICKLE1 PENK ITGA4 GFI1 RBP7 RASGRP1 PRKCE PAPPA PRKCH LTBP2 LONRF3 NOTCH2 | 8.19e-05 | 1035 | 107 | 14 | M9898 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 9.65e-05 | 350 | 107 | 8 | M1949 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 1.11e-04 | 357 | 107 | 8 | MM828 | |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | EPHB2 FN1 ADAMTS2 PRICKLE1 CNTNAP1 ITGA4 NIPAL3 LTBP2 KDM1B NOTCH2 | 1.11e-04 | 567 | 107 | 10 | M2129 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.36e-04 | 191 | 107 | 6 | MM17059 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 1.41e-04 | 276 | 107 | 7 | M3063 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_DN | 1.52e-04 | 195 | 107 | 6 | M9508 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CE_OLFM4HIGH_STEM_CELL | 1.55e-04 | 375 | 107 | 8 | M39162 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_BASOPHIL_UP | 1.56e-04 | 196 | 107 | 6 | M5524 | |
| Coexpression | GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_UP | 1.61e-04 | 197 | 107 | 6 | M9710 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | 1.63e-04 | 482 | 107 | 9 | M12144 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_DN | 1.65e-04 | 198 | 107 | 6 | M7716 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN | 1.65e-04 | 198 | 107 | 6 | M5776 | |
| Coexpression | GSE360_L_DONOVANI_VS_L_MAJOR_MAC_DN | 1.75e-04 | 200 | 107 | 6 | M5232 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | CACNA2D1 FN1 ADAMTS2 PRICKLE1 TNC LAMB1 SVEP1 RYR2 PAPPA LTBP2 | 3.29e-11 | 187 | 108 | 10 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.16e-09 | 194 | 108 | 9 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.33e-09 | 197 | 108 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-08 | 192 | 108 | 8 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.42e-08 | 193 | 108 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.52e-08 | 194 | 108 | 8 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 2.52e-08 | 194 | 108 | 8 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.95e-08 | 198 | 108 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.19e-08 | 200 | 108 | 8 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.19e-08 | 200 | 108 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-07 | 172 | 108 | 7 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-07 | 172 | 108 | 7 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.48e-07 | 185 | 108 | 7 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 3.75e-07 | 187 | 108 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 3.75e-07 | 187 | 108 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 4.03e-07 | 189 | 108 | 7 | 4178be3292ff4a8a1d8098f638d4b8d15164d2c6 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.03e-07 | 189 | 108 | 7 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.17e-07 | 190 | 108 | 7 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 4.17e-07 | 190 | 108 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.32e-07 | 191 | 108 | 7 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.64e-07 | 193 | 108 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.32e-07 | 197 | 108 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 5.32e-07 | 197 | 108 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.51e-07 | 198 | 108 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 5.70e-07 | 199 | 108 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.70e-07 | 199 | 108 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.70e-07 | 199 | 108 | 7 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.70e-07 | 199 | 108 | 7 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.89e-07 | 200 | 108 | 7 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Biopsy_IPF-Epithelial-KRT5-/KRT17+|Biopsy_IPF / Sample group, Lineage and Cell type | 5.89e-07 | 200 | 108 | 7 | 2fc7a3b3aea711ad3d96fd9513f4b40533056d86 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.26e-06 | 156 | 108 | 6 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.26e-06 | 156 | 108 | 6 | 605d95a900e1443d3f6aae163ef2e893d3293203 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intermediate_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 3.12e-06 | 165 | 108 | 6 | c3fa9225d2f9c9e821d4fbd2315fcc98ce1f1c55 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.67e-06 | 177 | 108 | 6 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.67e-06 | 177 | 108 | 6 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | AT1-AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.15e-06 | 180 | 108 | 6 | 3c7b2033821f9e34e2924bd8655f566edcbcc7d3 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.15e-06 | 180 | 108 | 6 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.15e-06 | 180 | 108 | 6 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.31e-06 | 181 | 108 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.48e-06 | 182 | 108 | 6 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.48e-06 | 182 | 108 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-06 | 183 | 108 | 6 | 6b5fa169477821355d1ab7aa11935cdfde1c339c | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.02e-06 | 185 | 108 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-06 | 185 | 108 | 6 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-06 | 185 | 108 | 6 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-06 | 185 | 108 | 6 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.21e-06 | 186 | 108 | 6 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.21e-06 | 186 | 108 | 6 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| ToppCell | Mesenchymal_cells-Adipo-CAR|World / Lineage and Cell class | 6.21e-06 | 186 | 108 | 6 | 6ca8ce7ced91d6308b7c056032ffec1b37c974bf | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.40e-06 | 187 | 108 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.23e-06 | 191 | 108 | 6 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.23e-06 | 191 | 108 | 6 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.23e-06 | 191 | 108 | 6 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-06 | 192 | 108 | 6 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-06 | 192 | 108 | 6 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-06 | 192 | 108 | 6 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.45e-06 | 192 | 108 | 6 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-06 | 192 | 108 | 6 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-06 | 192 | 108 | 6 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.45e-06 | 192 | 108 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.45e-06 | 192 | 108 | 6 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-06 | 192 | 108 | 6 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.45e-06 | 192 | 108 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 7.45e-06 | 192 | 108 | 6 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.67e-06 | 193 | 108 | 6 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.67e-06 | 193 | 108 | 6 | 22c58032e58730715224d7934968ce92d150b0e8 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.67e-06 | 193 | 108 | 6 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.67e-06 | 193 | 108 | 6 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.67e-06 | 193 | 108 | 6 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 7.67e-06 | 193 | 108 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.67e-06 | 193 | 108 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.67e-06 | 193 | 108 | 6 | 68089ba4123e2f9bea9aae0023a844b5a57bfc0e | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.67e-06 | 193 | 108 | 6 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.90e-06 | 194 | 108 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-06 | 194 | 108 | 6 | 29f83cdd63314fff41258937d70b881a5503bfcc | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.90e-06 | 194 | 108 | 6 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.90e-06 | 194 | 108 | 6 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 7.90e-06 | 194 | 108 | 6 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.90e-06 | 194 | 108 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-06 | 194 | 108 | 6 | d3db241ea316bbcde6d16618193b474591ad5ce4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.90e-06 | 194 | 108 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.90e-06 | 194 | 108 | 6 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.14e-06 | 195 | 108 | 6 | b0d408f8bc1701a87596ed55efcd90749fee33e6 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 8.14e-06 | 195 | 108 | 6 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 8.14e-06 | 195 | 108 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.14e-06 | 195 | 108 | 6 | a486a7acea0e91048cc48afa0dbd3926d30bc217 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.14e-06 | 195 | 108 | 6 | 2414b158dc7bdec43a9671544bfb7ffc5f5168fd | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.38e-06 | 196 | 108 | 6 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.38e-06 | 196 | 108 | 6 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.38e-06 | 196 | 108 | 6 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.62e-06 | 197 | 108 | 6 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.62e-06 | 197 | 108 | 6 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 8.62e-06 | 197 | 108 | 6 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.62e-06 | 197 | 108 | 6 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 8.62e-06 | 197 | 108 | 6 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| Drug | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | TRHDE CACNA2D1 FN1 LAMA1 LAMB1 SIRT6 ITGA4 ADCY9 ACTL7B PRKCD PRKCE PRKCG PRKCH PRKCQ | 2.59e-10 | 314 | 107 | 14 | CID000003542 |
| Drug | methoxamine | 1.52e-09 | 71 | 107 | 8 | CID000006081 | |
| Drug | Fura-2AM | 3.61e-09 | 79 | 107 | 8 | CID000105091 | |
| Drug | AC1L1B58 | 4.07e-09 | 29 | 107 | 6 | CID000001288 | |
| Drug | 1 Em | 5.38e-09 | 83 | 107 | 8 | CID000446621 | |
| Drug | RK-1409B | 6.03e-09 | 15 | 107 | 5 | CID003036125 | |
| Drug | dansyl-DAG | 6.03e-09 | 15 | 107 | 5 | CID000129493 | |
| Drug | AC1L1JQC | 1.23e-08 | 17 | 107 | 5 | CID000005157 | |
| Drug | daphnoretin | 1.23e-08 | 17 | 107 | 5 | CID005281406 | |
| Drug | kinin 9 | PENK SIRT6 ADCY9 MEP1A ACTL7B PRKCD PRKCE PRKCG PRKCH PLAU PRKCQ KLK1 VEGFA | 1.63e-08 | 363 | 107 | 13 | CID000006026 |
| Drug | Formyl | ACOT8 FN1 GART SIRT6 ITGA4 ACTL7B PRKCD PRKCE PRKCG PRKCH PRKCQ | 1.66e-08 | 238 | 107 | 11 | CID000123370 |
| Drug | dihydrosterculic acid | 1.70e-08 | 18 | 107 | 5 | CID000160788 | |
| Drug | puerarin | 1.85e-08 | 63 | 107 | 7 | CID005281807 | |
| Drug | indo-1 | 2.19e-08 | 99 | 107 | 8 | CID000105060 | |
| Drug | TAPP-Br | 2.30e-08 | 19 | 107 | 5 | CID000160326 | |
| Drug | fura 2 | 2.31e-08 | 65 | 107 | 7 | CID000057054 | |
| Drug | prazosin | CACNA2D1 PENK SIRT6 ADCY9 SLC25A40 PRKCD PRKCE PRKCG PRKCH PRKCQ | 2.61e-08 | 193 | 107 | 10 | CID000004893 |
| Drug | losartan | CACNA2D1 FN1 SIRT6 ITGA4 ITGB4 ACTL7B PRKCD PRKCE PRKCG PRKCH PRKCQ KLK1 VEGFA | 2.63e-08 | 378 | 107 | 13 | CID000003961 |
| Drug | PDBu | CACNA2D1 FN1 SIRT6 ITGA4 ADCY9 RASGRP1 PRKCD PRKCE PRKCG PRKCH PRKCQ | 2.64e-08 | 249 | 107 | 11 | CID000037783 |
| Drug | DiC8 | 3.01e-08 | 146 | 107 | 9 | CID000001323 | |
| Drug | strontium | 3.18e-08 | 68 | 107 | 7 | CID000104798 | |
| Drug | loperamide | 3.49e-08 | 105 | 107 | 8 | CID000003954 | |
| Drug | cepharanthine | 3.90e-08 | 70 | 107 | 7 | CID000010206 | |
| Drug | MDL 27,032 | 4.00e-08 | 21 | 107 | 5 | CID000163812 | |
| Drug | KS-619-1 | 4.00e-08 | 21 | 107 | 5 | CID000128369 | |
| Drug | K-259-2 | 4.00e-08 | 21 | 107 | 5 | CID006438946 | |
| Drug | broussochalcone A | 4.00e-08 | 21 | 107 | 5 | CID006438825 | |
| Drug | AC1L1HLA | 4.31e-08 | 71 | 107 | 7 | CID000004179 | |
| Drug | phorbol-13-acetate | TRHDE FN1 TNC SIRT6 ADCY9 RASGRP1 LIMK2 PRKCD PRKCE PRKCG PRKCH PRKCQ | 4.46e-08 | 326 | 107 | 12 | CID000499953 |
| Drug | C-1b | 4.76e-08 | 72 | 107 | 7 | CID006102740 | |
| Drug | AC1LDMDX | 4.95e-08 | 43 | 107 | 6 | CID000621355 | |
| Drug | Betamethasone-d5 | SDSL CACNA2D1 FN1 PENK LAMA1 LAMB1 PRPH2 CASP8 PPARD ITGA4 ITGB4 ADCY9 ACTL7B PRKCD PRKCE PRKCG PRKCH PLAU PRKCQ KLK1 MUC5AC FBN3 VEGFA | 5.09e-08 | 1340 | 107 | 23 | CID000003003 |
| Drug | I-Q-S | 5.34e-08 | 156 | 107 | 9 | CID000003540 | |
| Drug | AC1L4NFY | 6.56e-08 | 23 | 107 | 5 | CID000160335 | |
| Drug | calmidazolium chloride | 6.64e-08 | 160 | 107 | 9 | CID000002531 | |
| Drug | triphenylethylene | 7.52e-08 | 46 | 107 | 6 | CID000006025 | |
| Drug | chloroethylclonidine | 8.59e-08 | 47 | 107 | 6 | CID000104973 | |
| Drug | 3,4,5-trimethoxybenzoic acid | 8.59e-08 | 47 | 107 | 6 | CID000008357 | |
| Drug | angiotensin | FN1 PENK ADCY9 PRKCD PRKCE PRKCG PRKCH PLAU PRKCQ KLK1 VEGFA | 9.37e-08 | 282 | 107 | 11 | CID003083715 |
| Drug | phorbol 12,13-diacetate | 9.78e-08 | 48 | 107 | 6 | CID000072293 | |
| Drug | AC1L1BDQ | 1.30e-07 | 173 | 107 | 9 | CID000001394 | |
| Drug | acetylcholine | NRG1 PENK CASP8 SIRT6 ADCY9 PRKCD PRKCE PRKCG PRKCH ATP11A PRKCQ KLK1 | 1.35e-07 | 361 | 107 | 12 | CID000000187 |
| Drug | 5'-N-ethylcarboxamidoadenosine | 1.36e-07 | 174 | 107 | 9 | CID000104795 | |
| Drug | pseudohypericin | 1.55e-07 | 27 | 107 | 5 | CID005281751 | |
| Drug | pinacidil | 1.78e-07 | 87 | 107 | 7 | CID000004826 | |
| Drug | bisindolylmaleimide II | 1.88e-07 | 28 | 107 | 5 | CID000002397 | |
| Drug | aplysiatoxin | 1.88e-07 | 28 | 107 | 5 | CID000040465 | |
| Drug | NCDC | 1.88e-07 | 28 | 107 | 5 | CID000001583 | |
| Drug | SC-10 | 1.88e-07 | 28 | 107 | 5 | CID000005175 | |
| Drug | tetracaine | 1.93e-07 | 88 | 107 | 7 | CID000005411 | |
| Drug | kalinin | 2.25e-07 | 55 | 107 | 6 | CID000032518 | |
| Drug | Polychlorinated biphenyls | 2.26e-07 | 29 | 107 | 5 | CID000006636 | |
| Drug | C-1A | 2.43e-07 | 91 | 107 | 7 | CID009543473 | |
| Drug | lomustine; Down 200; 100uM; PC3; HT_HG-U133A | 2.63e-07 | 188 | 107 | 9 | 7050_DN | |
| Drug | Deptropine citrate [2169-75-7]; Down 200; 7.6uM; HL60; HT_HG-U133A | 2.88e-07 | 190 | 107 | 9 | 3144_DN | |
| Drug | (2S,3R)-Sphingosine | TRHDE PENK CASP8 SIRT6 RYR2 ACTL7B PRKCD PRKCE PRKCG PRKCH PLAU PRKCQ | 3.01e-07 | 389 | 107 | 12 | CID000001104 |
| Drug | DAPH2 | 3.10e-07 | 58 | 107 | 6 | CID006711154 | |
| Drug | quin2 | 3.27e-07 | 95 | 107 | 7 | CID000104841 | |
| Drug | aldosterone | CACNA2D1 FN1 TNC PPARD RYR2 PRKCD PRKCE PRKCG PRKCH PLAU PRKCQ KLK1 | 3.74e-07 | 397 | 107 | 12 | CID000005839 |
| Drug | taxol | NRG1 PENK LAMA1 LAMB1 CASP8 ITGB4 ACTL7B PRKCD PRKCE PRKCG PRKCH PLAU PRKCQ VEGFA | 3.77e-07 | 560 | 107 | 14 | CID000004666 |
| Drug | Ro-31-8425 | 3.81e-07 | 60 | 107 | 6 | CID000002404 | |
| Drug | dibutyryl cyclic 3',5'-AMP | CACNA2D1 FN1 PENK LAMA1 LAMB1 SIRT6 ADCY9 ACTL7B PRKCD PRKCE PRKCG PRKCH PLAU VEGFA | 3.85e-07 | 561 | 107 | 14 | CID000002460 |
| Drug | naphthalenesulfonamide | 4.46e-07 | 33 | 107 | 5 | CID000163571 | |
| Drug | AC1L1FGW | 4.46e-07 | 33 | 107 | 5 | CID000003231 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | CACNA2D1 FN1 CASP8 SIRT6 ADCY9 RYR2 ACTL7B RASGRP1 PPP3CB PRKCD PRKCE PRKCG PRKCH PRKCQ | 4.46e-07 | 568 | 107 | 14 | CID000000806 |
| Drug | phorbol acetate myristate | TRHDE NRG1 CACNA2D1 FN1 PENK CASP8 PPARD SIRT6 ITGA4 ITGB4 ADCY9 RYR2 ACTL7B RASGRP1 PRKCD PRKCE PRKCG PRKCH PLAU PRKCQ PRDM16 VEGFA | 4.72e-07 | 1399 | 107 | 22 | CID000004792 |
| Drug | noradrealine | CACNA2D1 PENK SIRT6 ADCY9 RYR2 ACTL7B SLC25A40 PRKCD PRKCE PRKCG PRKCH PRKCQ KLK1 VEGFA | 5.17e-07 | 575 | 107 | 14 | CID000000951 |
| Drug | Bay K 8644 | 5.53e-07 | 150 | 107 | 8 | CID000002303 | |
| Drug | isoproterenol | CACNA2D1 PENK SIRT6 ADCY9 RYR2 ACTL7B SLC25A40 PRKCD PRKCE PRKCG PRKCH PLAU PRKCQ KLK1 VEGFA | 5.56e-07 | 669 | 107 | 15 | CID000003779 |
| Drug | H2O2 | ACOT8 FN1 EGLN1 PENK PSMC3 CASP8 SIRT6 ITGA4 ITGB4 ADCY9 RYR2 ACTL7B PRKCD PRKCE KCNS3 PRKCG PRKCH PRKCQ PRDM16 VEGFA | 5.58e-07 | 1183 | 107 | 20 | CID000000784 |
| Drug | 1-stearoyl-2-arachidonylglycerol | 6.05e-07 | 15 | 107 | 4 | CID006443869 | |
| Drug | H-1152P | 6.75e-07 | 154 | 107 | 8 | CID000448043 | |
| Drug | phosphine oxide | 7.36e-07 | 107 | 107 | 7 | CID000166931 | |
| Drug | norathyriol | 8.07e-07 | 37 | 107 | 5 | CID005281656 | |
| Drug | HA1004 | 8.35e-07 | 109 | 107 | 7 | CID000003546 | |
| Drug | AC1L1ERT | 8.82e-07 | 69 | 107 | 6 | CID000002920 | |
| Drug | lidocaine | 9.02e-07 | 160 | 107 | 8 | CID000003676 | |
| Drug | BiM4 | 9.14e-07 | 283 | 107 | 10 | CID000002399 | |
| Drug | AGEPC | CACNA2D1 FN1 SIRT6 ITGA4 ACTL7B PRKCD PRKCE PRKCG PRKCH PLAU VEGFA | 9.51e-07 | 356 | 107 | 11 | CID000461545 |
| Drug | 4 alpha-phorbol 12,13-didecanoate | 9.61e-07 | 70 | 107 | 6 | CID000452543 | |
| Drug | NSC383468 | 9.61e-07 | 70 | 107 | 6 | CID000343585 | |
| Drug | thiopental | 1.00e-06 | 112 | 107 | 7 | CID003000715 | |
| Drug | 12-deoxyphorbol 13-isobutyrate | 1.06e-06 | 39 | 107 | 5 | CID000107855 | |
| Drug | isocycloheximide | FN1 PENK LAMA1 LAMB1 CASP8 SIRT6 ADCY9 ACTL7B ACSL1 MIB1 PRKCD PRKCE PRKCG PRKCH PLAU NR1H2 VEGFA | 1.07e-06 | 905 | 107 | 17 | CID000002900 |
| Drug | AC1L1JVU | 1.14e-06 | 72 | 107 | 6 | CID000005229 | |
| Drug | digoxigenine | 1.20e-06 | 40 | 107 | 5 | CID000015478 | |
| Drug | 1-stearoyl-2-arachidonoyl-sn-glycerol | 1.20e-06 | 40 | 107 | 5 | CID000001398 | |
| Drug | dipalmitin | 1.34e-06 | 18 | 107 | 4 | CID000068149 | |
| Drug | Cgp-42700 | 1.34e-06 | 18 | 107 | 4 | CID000188390 | |
| Drug | NSC-351907 | 1.37e-06 | 229 | 107 | 9 | CID000004016 | |
| Drug | DB04780 | 1.42e-06 | 170 | 107 | 8 | CID005459389 | |
| Drug | lavendustin A | 1.49e-06 | 171 | 107 | 8 | CID000003894 | |
| Drug | AC1L1DXE | CACNA2D1 PENK RYR2 ACTL7B PRKCD PRKCE PRKCG PRKCH PRKCQ VEGFA | 1.50e-06 | 299 | 107 | 10 | CID000002548 |
| Drug | antibiotic from Streptomyces | 1.55e-06 | 42 | 107 | 5 | CID000005153 | |
| Drug | benzenesulfonate | 1.55e-06 | 42 | 107 | 5 | CID000007371 | |
| Drug | R59022 | 1.57e-06 | 76 | 107 | 6 | CID000003012 | |
| Drug | methyl 2,5-dihydroxycinnamate | 1.69e-06 | 77 | 107 | 6 | CID000003248 | |
| Drug | sapintoxin A | 1.69e-06 | 19 | 107 | 4 | CID000108085 | |
| Drug | AC1L1JM9 | 1.74e-06 | 304 | 107 | 10 | CID000005103 | |
| Drug | SC-9 | 1.74e-06 | 43 | 107 | 5 | CID000124172 | |
| Disease | Autoimmune Lymphoproliferative Syndrome | 2.42e-06 | 8 | 105 | 3 | C1328840 | |
| Disease | rheumatoid arthritis | TRHDE ZNF438 CASP8 GFI1 RASGRP1 CTDP1 PRKCH SCAF11 PRKCQ PRDM16 | 6.15e-06 | 462 | 105 | 10 | EFO_0000685 |
| Disease | Nodular glomerulosclerosis | 1.39e-05 | 41 | 105 | 4 | C0017667 | |
| Disease | Diabetic Nephropathy | 1.84e-05 | 44 | 105 | 4 | C0011881 | |
| Disease | adipose tissue measurement | 2.02e-05 | 45 | 105 | 4 | EFO_0004764 | |
| Disease | Myocardial Infarction | 2.33e-05 | 95 | 105 | 5 | C0027051 | |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 3.36e-05 | 170 | 105 | 6 | EFO_0000685, EFO_0007791, EFO_0007837 | |
| Disease | Myocardial Preinfarction Syndrome | 3.75e-05 | 3 | 105 | 2 | C0086666 | |
| Disease | Angina, Unstable | 3.75e-05 | 3 | 105 | 2 | C0002965 | |
| Disease | chronic obstructive pulmonary disease (implicated_via_orthology) | 3.75e-05 | 3 | 105 | 2 | DOID:3083 (implicated_via_orthology) | |
| Disease | alpha-tocopherol measurement | 4.78e-05 | 20 | 105 | 3 | EFO_0007898 | |
| Disease | hypertension (implicated_via_orthology) | 9.69e-05 | 128 | 105 | 5 | DOID:10763 (implicated_via_orthology) | |
| Disease | Non-alcoholic Fatty Liver Disease | 1.16e-04 | 70 | 105 | 4 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 1.16e-04 | 70 | 105 | 4 | C3241937 | |
| Disease | Cerebral Hemorrhage | 1.34e-04 | 28 | 105 | 3 | C2937358 | |
| Disease | Glioblastoma | 1.85e-04 | 79 | 105 | 4 | C0017636 | |
| Disease | obesity | 2.29e-04 | 241 | 105 | 6 | EFO_0001073 | |
| Disease | Giant Cell Glioblastoma | 2.35e-04 | 84 | 105 | 4 | C0334588 | |
| Disease | Spinocerebellar Ataxia Type 2 | 2.42e-04 | 34 | 105 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 2.42e-04 | 34 | 105 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 2.42e-04 | 34 | 105 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 2.42e-04 | 34 | 105 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 2.42e-04 | 34 | 105 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 2.42e-04 | 34 | 105 | 3 | C0087012 | |
| Disease | cervical cancer | 2.42e-04 | 34 | 105 | 3 | C4048328 | |
| Disease | Spinocerebellar Ataxia Type 4 | 2.64e-04 | 35 | 105 | 3 | C0752122 | |
| Disease | Uterine Cervical Neoplasm | 2.64e-04 | 35 | 105 | 3 | C0007873 | |
| Disease | multiple sclerosis | ZNF438 PRICKLE1 MRGPRE CASP8 GFI1 RASGRP1 LIMK2 PLAU CLEC16A | 2.77e-04 | 594 | 105 | 9 | MONDO_0005301 |
| Disease | retinitis pigmentosa (is_implicated_in) | 4.23e-04 | 41 | 105 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | myocardial infarction (is_implicated_in) | 4.40e-04 | 99 | 105 | 4 | DOID:5844 (is_implicated_in) | |
| Disease | Neoplasm Invasiveness | 5.21e-04 | 184 | 105 | 5 | C0027626 | |
| Disease | hydroxy-leucine measurement | 5.57e-04 | 45 | 105 | 3 | EFO_0005276 | |
| Disease | Streptozotocin Diabetes | 6.11e-04 | 108 | 105 | 4 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 6.11e-04 | 108 | 105 | 4 | C0011853 | |
| Disease | Alloxan Diabetes | 6.11e-04 | 108 | 105 | 4 | C0002152 | |
| Disease | Posterior Choroidal Artery Infarction | 6.76e-04 | 11 | 105 | 2 | C0887799 | |
| Disease | Cerebral Infarction, Left Hemisphere | 6.76e-04 | 11 | 105 | 2 | C0751010 | |
| Disease | Anterior Choroidal Artery Infarction | 6.76e-04 | 11 | 105 | 2 | C0751012 | |
| Disease | Cerebral Infarction, Right Hemisphere | 6.76e-04 | 11 | 105 | 2 | C0751011 | |
| Disease | Subcortical Infarction | 6.76e-04 | 11 | 105 | 2 | C0751014 | |
| Disease | Cerebral Infarction | 6.76e-04 | 11 | 105 | 2 | C0007785 | |
| Disease | Diabetic Cardiomyopathies | 6.76e-04 | 11 | 105 | 2 | C0853897 | |
| Disease | Glioblastoma Multiforme | 6.77e-04 | 111 | 105 | 4 | C1621958 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.77e-04 | 195 | 105 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | Pain, Migratory | 7.16e-04 | 49 | 105 | 3 | C0751407 | |
| Disease | Suffering, Physical | 7.16e-04 | 49 | 105 | 3 | C0751408 | |
| Disease | Pain, Crushing | 7.16e-04 | 49 | 105 | 3 | C0458259 | |
| Disease | Pain, Splitting | 7.16e-04 | 49 | 105 | 3 | C0458257 | |
| Disease | Pain | 7.16e-04 | 49 | 105 | 3 | C0030193 | |
| Disease | Radiating pain | 7.16e-04 | 49 | 105 | 3 | C0234254 | |
| Disease | Pain, Burning | 7.16e-04 | 49 | 105 | 3 | C0234230 | |
| Disease | Ache | 7.16e-04 | 49 | 105 | 3 | C0234238 | |
| Disease | Pulmonary Thromboembolisms | 8.09e-04 | 12 | 105 | 2 | C0524702 | |
| Disease | Pulmonary Embolism | 8.09e-04 | 12 | 105 | 2 | C0034065 | |
| Disease | hypertension (is_marker_for) | 9.01e-04 | 53 | 105 | 3 | DOID:10763 (is_marker_for) | |
| Disease | vascular endothelial growth factor measurement | 1.06e-03 | 56 | 105 | 3 | EFO_0004762 | |
| Disease | asthma (is_marker_for) | 1.09e-03 | 126 | 105 | 4 | DOID:2841 (is_marker_for) | |
| Disease | Left ventricular noncompaction | 1.11e-03 | 14 | 105 | 2 | C1960469 | |
| Disease | extrinsic allergic alveolitis (is_marker_for) | 1.11e-03 | 14 | 105 | 2 | DOID:841 (is_marker_for) | |
| Disease | Malignant neoplasm of skin | 1.23e-03 | 59 | 105 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 1.23e-03 | 59 | 105 | 3 | C0037286 | |
| Disease | schizophrenia (biomarker_via_orthology) | 1.28e-03 | 15 | 105 | 2 | DOID:5419 (biomarker_via_orthology) | |
| Disease | brain edema (biomarker_via_orthology) | 1.28e-03 | 15 | 105 | 2 | DOID:4724 (biomarker_via_orthology) | |
| Disease | hyperinsulinism (biomarker_via_orthology) | 1.28e-03 | 15 | 105 | 2 | DOID:2018 (biomarker_via_orthology) | |
| Disease | Gastro-enteropancreatic neuroendocrine tumor | 1.28e-03 | 15 | 105 | 2 | C2930967 | |
| Disease | triiodothyronine measurement | 1.46e-03 | 16 | 105 | 2 | EFO_0008392 | |
| Disease | Cannabis Dependence | 1.65e-03 | 17 | 105 | 2 | C0006870 | |
| Disease | Astrocytosis | 1.65e-03 | 17 | 105 | 2 | C3887640 | |
| Disease | immature granulocyte count | 1.65e-03 | 17 | 105 | 2 | EFO_0803542 | |
| Disease | a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement | 1.65e-03 | 17 | 105 | 2 | EFO_0008011 | |
| Disease | Gliosis | 1.65e-03 | 17 | 105 | 2 | C0017639 | |
| Disease | type 1 diabetes mellitus | 1.77e-03 | 242 | 105 | 5 | MONDO_0005147 | |
| Disease | Gastric ulcer | 1.85e-03 | 18 | 105 | 2 | C0038358 | |
| Disease | response to clozapine | 1.85e-03 | 18 | 105 | 2 | GO_0097338 | |
| Disease | obesity (biomarker_via_orthology) | 1.91e-03 | 147 | 105 | 4 | DOID:9970 (biomarker_via_orthology) | |
| Disease | Usual Interstitial Pneumonia | 2.06e-03 | 19 | 105 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 2.06e-03 | 19 | 105 | 2 | C4721508 | |
| Disease | Contact Dermatitis | 2.10e-03 | 71 | 105 | 3 | C0011616 | |
| Disease | Contact hypersensitivity | 2.10e-03 | 71 | 105 | 3 | C0162351 | |
| Disease | Colonic Neoplasms | 2.16e-03 | 152 | 105 | 4 | C0009375 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 2.29e-03 | 20 | 105 | 2 | C4721952 | |
| Disease | Retinitis pigmentosa | 2.36e-03 | 74 | 105 | 3 | cv:C0035334 | |
| Disease | Non-Small Cell Lung Carcinoma | 2.38e-03 | 156 | 105 | 4 | C0007131 | |
| Disease | Autistic Disorder | 2.45e-03 | 261 | 105 | 5 | C0004352 | |
| Disease | non-small cell lung carcinoma | 2.45e-03 | 75 | 105 | 3 | EFO_0003060 | |
| Disease | Idiopathic Pulmonary Fibrosis | 2.52e-03 | 21 | 105 | 2 | C1800706 | |
| Disease | Malignant tumor of colon | 2.54e-03 | 159 | 105 | 4 | C0007102 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 2.60e-03 | 160 | 105 | 4 | DOID:5844 (biomarker_via_orthology) | |
| Disease | hemoglobin A1 measurement | 2.61e-03 | 520 | 105 | 7 | EFO_0007629 | |
| Disease | Endometrioma | 2.66e-03 | 161 | 105 | 4 | C0269102 | |
| Disease | Endometriosis | 2.66e-03 | 161 | 105 | 4 | C0014175 | |
| Disease | Asthma | 2.95e-03 | 80 | 105 | 3 | C0004096 | |
| Disease | sciatic neuropathy (implicated_via_orthology) | 3.02e-03 | 23 | 105 | 2 | DOID:11446 (implicated_via_orthology) | |
| Disease | Allodynia | 3.39e-03 | 84 | 105 | 3 | C0458247 | |
| Disease | Mechanical Allodynia | 3.39e-03 | 84 | 105 | 3 | C2936719 | |
| Disease | Hyperalgesia, Secondary | 3.39e-03 | 84 | 105 | 3 | C0751212 | |
| Disease | Hyperalgesia, Primary | 3.39e-03 | 84 | 105 | 3 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 3.39e-03 | 84 | 105 | 3 | C0751214 | |
| Disease | Tactile Allodynia | 3.39e-03 | 84 | 105 | 3 | C0751213 | |
| Disease | Hyperalgesia | 3.39e-03 | 84 | 105 | 3 | C0020429 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EVIMLACSFGNKHCH | 816 | Q9UKU6 | |
| GEGDMKMHCCVAAYI | 216 | O14734 | |
| ISQEFGERMAHCCLG | 76 | Q2M3D2 | |
| HPVVMKGLCAECGQD | 116 | Q9Y5B0 | |
| TAFHGCMELLKVDGQ | 501 | P78357 | |
| FKEEMAANVLLCGGC | 331 | Q9Y614 | |
| ECVMLCHGAKIGFFQ | 331 | P33121 | |
| GMNCHKQCKDLVVFE | 576 | O95267 | |
| FGGHQGTITCMDLCK | 491 | Q5XX13 | |
| CQGVVCAMKEAFGFI | 186 | O75534 | |
| QDCHARGMECKNLIG | 2216 | Q75N90 | |
| GHCQGDKSIFCRMEV | 1061 | O95450 | |
| DGTVCFGQLLGMCDH | 456 | Q9UF12 | |
| EMHCIDLQKSCIVGG | 571 | O95980 | |
| EKTFCVNGGECFMVK | 186 | Q02297 | |
| GISKCGTMLCHDFLG | 771 | Q9UPP5 | |
| ADINFLACVMECEGK | 41 | P01210 | |
| FGGHQGTITCMDLCK | 491 | O95170 | |
| EHQGNLKMCCELAFC | 466 | Q5VWQ8 | |
| LCMPGFKGVHCELEI | 481 | Q04721 | |
| ARQGLKCDACGMNVH | 256 | Q04759 | |
| IGEDVLHICMFALGC | 296 | Q6P499 | |
| FMLCVGHLEGGKDTC | 196 | P06870 | |
| CEMCGKTFGHAVSLE | 286 | Q99684 | |
| MSLLCRNKGCGQHFD | 1 | Q9UKP3 | |
| KQGLKCEDCGMNVHH | 256 | Q05655 | |
| CGKCHNEVVLAPMFE | 121 | P53671 | |
| DGKTHGNKCAMCAEL | 186 | Q9NQ38 | |
| GRMHGNKCALCAEIF | 251 | Q9NQ38 | |
| LDGKIHGNTCSMCEA | 591 | Q9NQ38 | |
| DAEGHCKLADFGMCK | 541 | Q02156 | |
| IGRCMCKAGFEAVEN | 251 | P29323 | |
| DCFLGLHDRKMCVLG | 826 | O95373 | |
| HCMCTVGDKLYVIGG | 486 | Q9P2J3 | |
| RHNTKGLNCELCMDF | 301 | P07942 | |
| GKLHVMEELCVFSFC | 86 | Q9BQ31 | |
| LYGLVHQGMKCSCCE | 121 | P05129 | |
| VKVGHTVGMDCQECT | 5286 | P98088 | |
| LIHCVKGCEPFMGDN | 1551 | Q13219 | |
| HSFAKCIEVMGDGCL | 771 | O00410 | |
| ACADLIFLGCHMVAI | 66 | Q86SM8 | |
| LPCCNRGHMVGFKED | 746 | P16144 | |
| NISLCGHEGKKMALC | 716 | A8MWY0 | |
| NECTLCMKIREGGHN | 61 | P20155 | |
| KNMIFLCGHGTCQLC | 971 | Q86YT6 | |
| VMHAVCEQCGLKING | 121 | Q96MT3 | |
| KMAALHCALYCGQGA | 426 | A4D1B5 | |
| CEQLGISMHKFGERC | 451 | Q8NB78 | |
| CGNCSRIFHGEKLMN | 996 | P54289 | |
| QKFGFCPMAAHEEIC | 456 | P02751 | |
| FHCQNGCILGDEMGL | 61 | Q86WJ1 | |
| CPAEVRLGMGHCFVK | 196 | Q6PD62 | |
| AGECMNKLKCGAAEA | 41 | Q9H2H0 | |
| ADHAYCCIEMGLGMI | 456 | O60503 | |
| NMDCFICCILSHGDK | 306 | Q14790 | |
| CMNKHGICVVDDFLG | 201 | Q9GZT9 | |
| CDQGYIMVRKGHCQD | 956 | Q14767 | |
| LCGATFHMCKEAEHQ | 41 | Q9UH90 | |
| CEMCKQGLLVDLGDF | 711 | Q8NA82 | |
| HCLNFLCNFGKMESG | 896 | P13612 | |
| LMCACEHGHKEIAGL | 776 | Q63ZY3 | |
| MRVAVAGCCHGELDK | 1 | Q9UK59 | |
| DHHMEFCRVCKDGGE | 446 | Q14839 | |
| CIDFHGLMCTVAKLG | 66 | Q8N7B9 | |
| VCGDIHGQFFDLMKL | 96 | P16298 | |
| THVERCMLCQAKGFI | 876 | Q92622 | |
| KEVGFPESCNHVFCM | 51 | Q99590 | |
| KEDMETKCFICGIGN | 4881 | Q92736 | |
| YANHVLLMSDGKCGC | 56 | Q8TDX9 | |
| MPLCGHKEVDHFFCE | 166 | Q9GZK3 | |
| DCFLGHHDRKMCIIG | 826 | O15397 | |
| CEHMGLAKLACASIN | 181 | Q8NH55 | |
| CEHMGIAKLSCGNIR | 181 | Q8NH60 | |
| VKLVACGGCHMVVFA | 351 | Q92834 | |
| QHLCLEQGFGGCMKD | 1851 | O75445 | |
| LLVQECMVHDCADGK | 141 | P00749 | |
| NMECRVCGDKASGFH | 71 | Q03181 | |
| DHEGHAFVCFCGIMK | 346 | Q3MII6 | |
| GLMDHLCVCEEGGNK | 61 | Q8TBP6 | |
| RHTGIKDFMCELCGK | 1161 | P57071 | |
| GKSVDFCCSHLLGMV | 61 | Q7Z6Z6 | |
| IKDISVGGMCICYGH | 261 | P25391 | |
| GSGQAHECKDCERMF | 276 | Q9HAZ2 | |
| MLGHELCRVCGDKAS | 81 | P55055 | |
| LDHCTFEKANICGMI | 266 | Q16819 | |
| ELHGNMFVEECAKCK | 131 | Q8N6T7 | |
| EGQDMPRCIAHFCEK | 2071 | Q4LDE5 | |
| GIGHFCQEMAKKGCR | 51 | Q96GA7 | |
| SAGCIMKDVHLACLE | 576 | Q2KHT3 | |
| ENNMEFKECCIEGHV | 421 | P98196 | |
| RIHMGEKAYQCKECG | 276 | Q8IYI8 | |
| VCNDCGKAFMHKAQL | 216 | Q5T5D7 | |
| EASHKCGECGMVFQR | 566 | O95625 | |
| LMECHECGKAFSRGS | 206 | Q8N9K5 | |
| IDMLQIEFKCCGNNG | 156 | P23942 | |
| LHLEMFCEGQVCKQT | 116 | Q96R05 | |
| FNGAQCKAVCVEAGM | 391 | P17980 | |
| QCVCHEGFMGKDCKE | 546 | P24821 | |
| RCMLCNKEFLGGHIV | 546 | Q8IZM8 | |
| CNKHDTIGQDLVAMC | 506 | P22102 | |
| RVHMGEKLYNCDVCG | 196 | Q9UK10 | |
| RVHVGEKLFMCDVCG | 196 | Q12901 | |
| RHQGKSLMCEVCAFA | 506 | P52746 | |
| HIGEMSFLQHNKCEC | 116 | P15692 | |
| TGFLHMDCEIKGRPC | 586 | Q6PJF5 | |
| LMCCEFCAKVFGHIR | 566 | Q7Z4V0 | |
| FCKNHGDVTAEVMCP | 196 | Q8N8Y2 | |
| ECLTCGKSFRQGMHL | 576 | O14978 | |
| GHCKLADFGMCKEGI | 491 | P24723 | |
| GEDCAELMGLHNCVY | 661 | Q496Y0 | |
| GEECVGAIVCKLDMH | 261 | Q147X3 |